HSHHSH Health Technology Supplier Hub
Home › Suppliers › Olympus

Olympus

HQ Japan · Asia-Pacific

Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.

At a glance

Financial health
Band: Fair
Customer rating
No reviews yet

Financial health

Band: FairListed: 7733.T

FY2025 revenue ¥1.01tn (+1.3%); operating margin 9.6%; net income ¥68.2bn.

Balance sheet figures not captured from release.

Source: official results release · Year ended 2026-03-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.

YearRevenueGrowthOperating profitNet incomeCovers
FY2025JP¥1tn+1.3%JP¥97.1bnJP¥68.2bnOlympus

Products & services

Products not yet catalogued.

Financial

FY2025 revenue ¥1.01tn (+1.3%); operating margin 9.6%; net income ¥68.2bn.

Balance sheet figures not captured from release.

Researched 8 Nov 2026

Adverse media

Not yet researched.

Cyber & information governance

Not yet researched.

Regulatory & clinical safety

Not yet researched.

Contract performance

Not yet researched.

Competitors

No competitors linked yet.

Customer reviews

No reviews yet